SCHEMBL18201271

SCHEMBL18201271

c1ccc(-c2ccc(-c3cc(-c4ncc(-c5nc6ccccc6c6c5ccc5ccccc56)c5ccccc45)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
KDM4E B2RXH2 2/20 0.40
PTGES O14684 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
NTSR1 P30989 1/20 0.38
DHODH Q02127 3/20 0.36
ACACA Q13085 2/20 0.35
ACHE P22303 1/20 0.35
ATM Q13315 1/20 0.34
GLA P06280 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200866 1.00 MAPT (0.40) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18200870 1.00 MAPT (0.40) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18201254 0.98 MAPT (0.42) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18200703 0.91 MAPT (0.40) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18200697 0.91 MAPT (0.40) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18200706 0.91 MAPT (0.40) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18200805 0.91 KDM4E (0.43) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18201223 0.89 MAPT (0.42) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18201219 0.86 KDM4E (0.43) MAPTALDH1A1HPGDKDM4EPTGES
SCHEMBL18201252 0.86 MAPT (0.43) MAPTALDH1A1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885ALDH1A1 85/4885HPGD 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.